Neuronetics Inc
For the period ended Dec 31, 2023. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 8, 2024
STIM$2.18+1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
(In thousands, except per share data)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · December 31, | ||||||
| · · 2023 · 2022 | ||||||
| Assets · · · | ||||||
| Current assets: · · · | ||||||
| Cash and cash equivalents | | $59,677 | | $70,340 | ||
| Accounts receivable, net | | 15,782 | | 13,591 | ||
| Inventory | | 8,093 | | 8,899 | ||
| Current portion of net investments in sales-type leases | | 905 | | 1,538 | ||
| Current portion of prepaid commission expense | | 2,514 | | 1,997 | ||
| Current portion of notes receivable | | 2,056 | | 230 | ||
| Prepaid expenses and other current assets | | 4,766 | | 2,174 | ||
| Total current assets | | 93,793 | | 98,769 | ||
| Property and equipment, net | | 2,009 | | 1,991 | ||
| Operating lease right-of-use assets | | 2,773 | | 3,327 | ||
| Net investments in sales-type leases | | 661 | | 1,222 | ||
| Prepaid commission expense | | 8,370 | | 7,568 | ||
| Long-term notes receivable | | 3,795 | | 362 | ||
| Other assets | | | 4,430 | | | 3,645 |
| Total assets | | $115,831 | | $116,884 | ||
| Liabilities and Stockholders’ Equity | | | | | ||
| Current liabilities: | | | | | | |
| Accounts payable | | $4,752 | | $2,433 | ||
| Accrued expenses | | 12,595 | | 14,837 | ||
| Deferred revenue | | 1,620 | | 1,980 | ||
| Current portion of operating lease liabilities | | 845 | | 824 | ||
| Current portion of long-term debt, net | | — | | 13,125 | ||
| Total current liabilities | | 19,812 | | 33,199 | ||
| Long-term debt, net | | 59,283 | | 22,829 | ||
| Deferred revenue | | 200 | | 829 | ||
| Operating lease liabilities | | 2,346 | | 2,967 | ||
| Total liabilities | | 81,641 | | 59,824 | ||
| Commitments and contingencies (Note 18) | | — | | — | ||
| Stockholders’ equity: | | | | |||
| Preferred stock, $0.01 par value: 10,000 shares authorized; no shares issued or outstanding on December 31, 2023 and December 31, 2022 | | — | | — | ||
| Common stock, $0.01 par value: 200,000 shares authorized; 29,092 and 27,268 shares issued and outstanding on December 31, 2023 and December 31, 2022, respectively | | 291 | | 273 | ||
| Additional paid-in capital | | 409,980 | | 402,679 | ||
| Accumulated deficit | | (376,081) | | (345,892) | ||
| Total Stockholders' equity | | 34,190 | | 57,060 | ||
| Total liabilities and Stockholders’ equity | | $115,831 | | $116,884 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.